-
Changchun GeneScience Pharmaceutical Expands Reach with HuChuang Union Partnership
•
Changchun GeneScience Pharmaceutical Co., Ltd, a Chinese pharmaceutical enterprise, has established a partnership with HuChuang Union, a provider of assisted reproduction solutions. This strategic alliance grants GeneScience Pharma exclusive commercialization rights to HuChuang Union’s marketed product portfolio in designated regions within China. The collaboration extends further, with both parties planning…
-
Changchun GeneScience to Distribute TWi Pharma’s Megestrol in China and Southeast Asia
•
Changchun GeneScience Pharmaceutical Co., Ltd, a biopharmaceutical company based in China, has entered into an agency collaboration agreement with Taiwan’s TWi Pharmaceuticals, Inc. for the distribution of the latter’s megestrol in several Asian markets. According to the agreement, the financial details of which were not disclosed, GeneScience will assume the…
-
Junde Pharmaceuticals Licenses Weight-Reducing Capsule JTX-102 to Changchun GeneScience
•
Xiamen Junde Pharmaceutical Technology Co., Ltd., a China-based pharmaceutical company, has entered into a licensing agreement with Changchun GeneScience Pharmaceutical Co., Ltd., granting the latter exclusive commercialization rights for JTX-102, a gastric volume-occupying and weight-reducing capsule, across China, including mainland China, Hong Kong, and Macau. Under the terms of the…
-
Changchun High & New Technology to Transfer 7.42% Stake to Ex-Wife in Divorce Settlement
•
Changchun High & New Technology Industries (Group) Inc., (SHE: 000661) has announced plans to transfer 30,014,100 shares, representing a 7.42% stake, to Wang Simian, the ex-wife of company shareholder Jin Lei and founder of subsidiary Changchun GeneScience Pharmaceutical Co., Ltd., as part of their divorce agreement. Based on the estimated…
